CLB — Core Laboratories Income Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMid CapNeutral

Annual income statement for Core Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	487	470	490	510	524
Cost of Revenue
Gross Profit	113	102	96.1	110	103
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	564	425	448	455	465
Operating Profit	-76.8	45.3	41.5	54.6	58.6
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-91.2	36.1	30	41.2	46.2
Provision for Income Taxes
Net Income After Taxes	-97.1	20.2	19.7	37	32.2
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-97.6	19.7	19.5	36.7	31.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-97.6	19.7	19.5	36.7	31.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.209	0.405	0.447	0.82	0.673
Dividends per Share